Thu, April 14, 2022
Wed, April 13, 2022
Tue, April 12, 2022

Amit Hazan Maintained (TXG) at Hold with Decreased Target to $85 on, Apr 13th, 2022

Amit Hazan of Goldman Sachs, Maintained "10x Genomics, Inc." (TXG) at Hold with Decreased Target from $95 to $85 on, Apr 13th, 2022.

Amit has made no other calls on TXG in the last 4 months.



There is 1 other peer that has a rating on TXG. Out of the 1 peers that are also analyzing TXG, 0 agree with Amit's Rating of Hold.



This is the rating of the analyst that currently disagrees with Amit


  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $150 on, Thursday, February 17th, 2022